Yahoo Web Search

Search results

1. • Analyst Report: Teva Pharmaceutical Industries Limited

     Morningstar Research via Yahoo Finance· 2 days ago

     Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales ...

2. • Teva Pharmaceutical Indus's Options Frenzy: What You Need to Know - Teva Pharmaceutical Indus (NYSE:...

     Benzinga· 4 days ago

     Loading... Loading... Investors with a lot of money to spend have taken a bearish stance on Teva Pharmaceutical Indus TEVA . And retail ...

3. • Teva- Pharmaceutical Industries Ltd. ADR (TEVA) receives a Neutral rating from JP Morgan – Knox...

     Knox Daily· 6 days ago

     In a filing, Teva- Pharmaceutical Industries Ltd. ADR revealed its Chief Accounting Officer Weiss Amir unloaded Company’s shares for reported $0.21 million ...

4. • Teva Pharmaceutical Industries (NYSE:TEVA) Downgraded by StockNews.com to “Buy”

     ETF DAILY NEWS· 6 days ago

     Several other equities research analysts have also recently commented on TEVA. JPMorgan Chase & Co. raised Teva Pharmaceutical Industries ...

5. • Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.

     Morningstar· 6 days ago

     Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA

6. • 

     Big Pharma Teva Accused of Delaying Generic Drug Competition | Connecticut Law Tribune

     Law.com· 4 days ago

     Lawsuits against large pharmaceutical companies alleging the use of inaccurate patent listings to...

7. • 

     Israel stocks higher at close of trade; TA 35 up 0.25% By Investing.com

     Investing.com· 3 hours ago

     Israel stocks higher at close of trade; TA 35 up 0.25%

8. • Small Business - Salisbury Post | Salisbury Post

     The Salisbury Post· 6 days ago

     NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- Bleichmar Fonti & Auld LLP is investigating the WideOpenWest (NYSE: WOW) merger with DigitalBridge and Crestview. If you invested in WideOpenWest you are encouraged to obtain additional information

9. • 

     Exelixis (EXEL) Settles Cabometyx Patent Litigation With Cipla

     Zacks via Yahoo Finance· 5 days ago

     Exelixis (EXEL) resolves two patent litigations and grants Cipla a license to market generic...

10. • 10 drugs now in shortage

      Becker’s Hospital Review· 4 days ago

      About a month after the number of ongoing drug shortages reached a 23-year record, more than four dozen patient advocacy groups wrote to legislators, urging them to address the shortages. A ...